stars 1 stars 2 stars 3

COPSAC is a clinical research unit for paediatric asthma research with the aim of developing evidence-based prevention strategies. COPSAC’s method is prospective clinical birth cohort studies of which two (COPSAC2000 and COPSAC2010) are currently followed at the research unit. Endophenotyping is based on daily diary cards and comprehensive longitudinal objective assessments exploring systems biology and gene-environment interactions in the origin of atopic diseases. COPSAC comprises a multidisciplinary research cluster with competences in pediatrics, pulmonology, allergology, dermatology, microbiology, immunology, genetics and statistics, and participates in national and international research collaborations. Novel findings are communicated through publications in international peer-reviewed journals and textbooks, and through lectures at international scientific meetings.

COPSAC Questions

The COPSAC annual revenue was $5 million in 2026.

24 people are employed at COPSAC.

COPSAC is based in Næstved, Zealand.

The NAICS codes for COPSAC are [541, 5417, 54, 541713, 54171].

The SIC codes for COPSAC are [873, 87].

Top COPSAC Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users